Stocks in news: DMart, Reliance Power, Bajaj Finance, Sundaram-Clayton, Bank of Baroda

M&M Financial is likely to be in focus as the company said it is expecting a 1% year-on-year decline in the overall disbursement in the second quarter.

ETtech
Aarti Drugs received a UK MHRA certificate of GMP compliance from a manufacturer for the arm's Baddi manufacturing facility.
Domestic markets saw a sharp plunge on Thursday, dropping over 2% due to weak global cues. In today's trade, shares of DMart, Reliance Power, Bajaj Finance, Sundaram-Clayton, Bank of Baroda among others will be in focus due to various news developments.

DMart
DMart reported 14% growth in its standalone revenues at Rs 14,050 crore for the second quarter and added a net of 6 stores.


M&M Financial
M&M Financial is likely to be in focus as the company said it is expecting a 1% year-on-year decline in the overall disbursement in the second quarter.

Bank of Baroda
The state lender reported an 11.6% year-on-year growth in its global advances at Rs 11.43 lakh as on September 2024, while global deposits shot up by over 9% to Rs 13.63 lakh crore.

Read more: Here's the trade setup for today's session

Bajaj Finance
ADVERTISEMENT
Bajaj Finance's new loans booked grew by 14% to 9.69 mm in the second quarter as compared to 8.53 mm in Q2 of FY24. Assets under management (AUM) rose 29% to nearly Rs 3.73 lakh crore as of September 2024.

Sundaram-Clayton
Sundaram-Clayton has launched a qualified institutional placement on Thursday and fixed a floor price of Rs 2,320.78 per share.

Reliance Power
The Board of Reliance Power approved a raising $500 million unsecured foreign currency convertible bonds (FCCBs) at 5% per annum interest. The bonds have a 10 years long tenure.

Hindustan Construction
Zurich district court has extended Steiner AG's provisional debt moratorium by 4 months until February 7, 2025.

ADVERTISEMENT
Aarti Drugs
Aarti Drugs received a UK MHRA certificate of GMP compliance from a manufacturer for the arm's Baddi manufacturing facility.

Shilpa Medicare
Shilpa Medicare arm Shilpa Pharma Life Sciences received a certificate of suitability (CEP) from European Directorate for the quality of medicines and healthcare (EDQM) for API.
ADVERTISEMENT


ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › News › Stocks in news: DMart, Reliance Power, Bajaj Finance, Sundaram-Clayton, Bank of Baroda
Text Size:AAA
Success
This article has been saved

*

+